Completed

GROImpact of Diet Composition on Energy Balance and Satiety During Infancy

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Type of Formula

+ Type of Formula

Other
Who is being recruted

+11 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Interventional
Study Start: November 2012
See protocol details

Summary

Principal SponsorMonell Chemical Senses Center
Last updated: November 22, 2019
Sourced from a government-validated database.Claim as a partner

Study start date: November 2, 2012

Actual date on which the first participant was enrolled.

This is a randomized clinical trial of infants whose parents decided to formula feed them; mother-infant dyads will be randomized when infant is 2 weeks of age to one of 2 groups. The groups will differ in the composition of the formula fed to the infant during the first year of life.

Principal SponsorMonell Chemical Senses Center
Last updated: November 22, 2019
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

113 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

5 inclusion criteria required to participate
A healthy, term ( >= 37 and <= 42 week gestation at birth), singleton infant

At the time of enrollment, infant must be <= 14 days old (Date of birth=day 0)

Birth weight between 2500 - 4500 grams

Infant must be consuming a standard cow's milk protein infant formula and have been receiving a standard cow's milk protein infant formula for at least the past 2 days prior to enrollment

Show More Criteria

6 exclusion criteria prevent from participating
Dyad be the relative (son, daughter, niece, nephew, cousin, aunt, uncle, sibling) of ancillary personnel connected with the study

Infant has condition requiring infant feedings other than feeding cow milk formula from a bottle

Infant has evidence of significant cardiac, respiratory, endocrinologic, hematologic, gastrointestinal, or other systemic diseases. For example, infant must not be receiving insulin or growth hormone

Infant has major congenital malformations (i.e. cleft palate, hemangiomas, extremity malformation)

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Infants are randomized to feed standard cow milk formula during first year of life

Group II

Experimental
Infants are randomized to feed extensively hydrolyzed infant formula during first year of life

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Monell Chemical Senses Center

Philadelphia, United StatesOpen Monell Chemical Senses Center in Google Maps
CompletedOne Study Center